# Exelon Corporation (EXC) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Utilities / Multi-Utilities. Price $45.50, market value $47.1 billion.

## Valuation
- **P/E (trailing): 17.8×** (5-yr avg 20.1×). Exelon Corporation trades at 17.8× trailing earnings, close to its own five-year average of 20.1×. The Utilities median in the September 2026 study was 21.2×. Forward P/E is 15.0×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 1.9×**. Each dollar of revenue is priced at 1.9×.
- **Price / book: 1.6×**. The shares trade at 1.6× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 10.5×**. Enterprise value is 10.5× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: -4.1%** (5-yr avg -7.7%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 5.6%**. The inverse of the P/E: 5.6% of the price is earned each year.

## Profitability
- **Operating margin: 20.8%**. 20.8% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 11.4%**. 11.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 9.6%**. 9.6% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 5.4%**. Return on all capital, debt included, is 5.4%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 2.4%**. Each dollar of assets produces 2.4% of profit.

## Growth
- **Revenue growth (1 yr): 5.3%** (3-yr 8.3%/yr, 5-yr 7.8%/yr). Revenue grew 5.3% over the last year, against 7.8% a year compounded over five years: growth is slowing.

## Financial health
- **Debt to equity: 1.70**. Debt is 1.70 times equity, a leveraged balance sheet, which is normal for utilities.
- **Net debt / EBITDA: 5.3×**. It would take 5.3 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Current ratio: 0.92** (quick 0.92). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.01**. A Z-score of 1.01 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 3.69%** ($1.66 per share, trailing). Exelon Corporation yields 3.69%, an income-level yield.
- **Payout ratio: 58%**. 58% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 11**. 11 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 7.9%/yr** (1-yr 5.3%). The dividend has grown 7.9% a year over five years.

## Analyst view
- **Analyst consensus: hold** (17 analysts). 17 analysts cover Exelon Corporation; the consensus is hold, with an average price target of $47.71 (+5% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 3.4%** (YTD 8.5%, 3-mo 1.8%). The shares are up 3.4% over twelve months including dividends.
- **From 52-week high: -10.2%** (14.5% above the low). Trading 10% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 75**. An RSI of 75 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): -0.24** (volatility 20%). Beta of -0.24 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=EXC · Page: https://foliofundamentals.com/stocks/exc

Not investment advice.